TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
4.640
+0.010 (0.22%)
Apr 24, 2026, 4:00 PM EDT - Market closed
TriSalus Life Sciences Market Cap
TriSalus Life Sciences has a market cap or net worth of $284.96 million as of April 27, 2026. Its market cap has increased by 65.64% in one year.
Market Cap
284.96M
Enterprise Value
298.96M
1-Year Change
65.64%
Ranking
Category
Stock Price
$4.64
Market Cap Chart
Since February 8, 2021, TriSalus Life Sciences's market cap has decreased from $328.75M to $284.96M, a decrease of -13.32%. That is a compound annual growth rate of -2.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 284.96M | -18.29% |
| Dec 31, 2025 | 348.75M | 128.28% |
| Dec 31, 2024 | 152.77M | -31.30% |
| Dec 29, 2023 | 222.38M | -29.05% |
| Dec 30, 2022 | 313.44M | 1.52% |
| Dec 31, 2021 | 308.75M | -6.08% |
| Feb 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Delcath Systems | 373.49M |
| Viemed Healthcare | 372.90M |
| ClearPoint Neuro | 353.24M |
| Standard BioTools | 350.87M |
| CapsoVision | 302.52M |
| RxSight | 299.18M |
| Senseonics Holdings | 294.71M |
| Profound Medical | 253.32M |